Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells

Journal of Clinical Oncology

Volumn 17, Issue 7, 1999, Pages 2198-2207

  Schilder, Russell J ^a   Johnson, Steven ^a   Gallo, James ^a   Kindsfather, Scott ^a   Rogers, Barbara ^a   Bookman, Michael A ^a   Millenson, Michael M ^a   Boente, Matthew ^a   Rosenblum, Norman ^a   Litwin, Samuel ^a   Ozols, Robert F ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE CLEARANCE; DEHYDRATION; DIARRHEA; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; ERYTHROCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOCYTE COUNT; PERIPHERAL BLOOD STEM CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

EID: 0033024865     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.7.2198     Document Type: Article

References (29)

1. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
2. Zittoun RA, Mandelli F, Willemze R, et al: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217-223, 1995
3. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483-2489, 1995
4. Attal M, Harousseau J-L, Stoppa A-M, et al: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91-97, 1996
5. Broun E, Nichols C, Turns M, et al: Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Cancer 73:1716-1720, 1994
6. Peters W, Ross M, Vredenburgh J, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high risk primary breast cancer. J Clin Oncol 11:1132-1143, 1993
7. Legros M, Dauplat J, Fleury J, et al: High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results. J Clin Oncol 15:1302-1308, 1997
8. Norton L, Day R: Potential innovations in scheduling of cancer chemotherapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia, PA, Lippincott, 1991, pp 57-72
9. Mc Guire WP, Hoskins WJ, Brandy MF, et al: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334:1-6, 1996
10. Stuart G, Bertelsen K, Mangioni C, et al: Updated analysis shows a highly significant improved overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer: Mature results of the EORTC-GCCG, NOCOVA, NCIC CTG and Scottish Intergroup Trial. Proc Am Soc Clin Oncol 17:361a, 1998 (abstr 1394)
11. Bookman MA, McGuire WP, Kilpatrick D, et al: Carboplatin and paclitaxel in ovarian carcinoma: A phase I study of the Gynecologic Oncology Group. J Clin Oncol 14:1895-1902, 1996
12. Langer CL, Leighton JC, Comis RL, et al: Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995
13. Shea TC, Flaherty M, Elias A, et al: A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol 7:651-661, 1989
14. Shea TC, Mason JR, Storniolo AM, et al: Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: A novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 10:464-473, 1992
15. Kaye S, Paul J, Cassidy J, et al: Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. J Clin Oncol 14:2113-2119, 1996
16. McGuire WP, Hoskins W, Brady M, et al: Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 13:1589-1599, 1995
17. Jakobsen A, Bertelsen K, Andersen JE, et al: Dose-effect study of carboplatin in ovarian cancer: A Danish Ovarian Cancer Group Study. J Clin Oncol 15:193-198, 1997
18. Gore M, Mainwaring P, A'Hern R, et al: Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. J Clin Oncol 16:2426-2434, 1998
19. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 17:1748-1756, 1989
20. Cockcroft DW, Gault MH: Prediction of creatinine clearance from a serum creatinine. Nephron 16:31-36, 1976
21. Schilder RJ, LaCreta FP, Perez RP, et al: Phase I pharmacokinetic study of ormaplatin (Tetraplatin, NSC 363812) administered on a day 1 and day 9 schedule. Cancer Res 54:709-717, 1994
22. Laub PB, Gallo JM. NCOMP: A windows-based computer program for noncompartmental analysis of pharmacokinetic data. J Pharm Sci 85:393-395, 1996
23. Shea TC, Graham M, Bernard S, et al: A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer. Semin Oncol 22:80-85, 1995 (suppl 12)
24. Aghajanian C, Fennelly D, Shapiro F, et al: Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer. J Clin Oncol 16:1852-1860, 1998
25. Schilder RJ, Goldberg M, Rogers B, et al: Phase II trial of high-dose induction chemotherapy in patients (pts) with stage IIIA non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 16:481a, 1997 (abstr 1732)
26. Viens P, Maraninchi D: High-dose chemotherapy and autologous marrow transplantation for common epithelial ovarian carcinoma, in Armitage JO, Antman KH (eds): High-Dose Cancer Therapy (ed 2). Baltimore, MD, Williams & Wilkins, 1995, pp 847-854
27. Gianni AM, Bregni M, Siena S, et al: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290-1297, 1997
28. Bonadonna G, Zambetti M, Valagussa P: Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. JAMA 273:542-547, 1995
29. Hudis C, Seidman A, Raptis G, et al: Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience. Semin Oncol 23:58-64, 1996 (suppl 1)